Signe Diness Vindeløv

Author

Also Known As

S. D. Vindelov, S. D. Vindeløv, S. Diness Vindelov, S. Diness Vindeløv, S.D. Vindeløv, Signe Diness Vindeløv, Signe D. Vindeløv, Vindeløv, Signe Diness

Publications

804

Citations

H-Index

Concepts

All Affiliations

Creighton University Rigshospitalet Agostino Gemelli University Polyclinic Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"The US Oncology Network

About

Signe Diness Vindeløv is an author at Creighton University specializing in medicine, cell signaling, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	800
2	Cell Biology	3	3	410
3	Health Sciences	1	1	367
4	Biochemistry	1	1	330
5	Cellular Physiology	1	1	330

Signe Diness Vindeløv

Publications

800

Citations

H-Index

Page 1

	Year	Citations
Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study Robert L. Coleman, Domenica Lorusso, Christine Gennigens, The Lancet Oncology Tisotumab VedotinCervical CancerMetastatic Cervical CancerMedicineClinical Trials	2021	367
Transformation-Associated Changes in Sphingolipid Metabolism Sensitize Cells to Lysosomal Cell Death Induced by Inhibitors of Acid Sphingomyelinase Nikolaj H.T. Petersen, Ole Dines Olsen, Line Groth‐Pedersen, Cancer Cell MitophagySignal TransductionBiochemistryApoptosisAutophagy	2013	330
Excess sphingomyelin disturbs ATG9A trafficking and autophagosome closure Elisabeth Corcelle–Termeau, Signe Diness Vindeløv, Saara Hämälistö, Autophagy Cell AutophagyMitophagyIntracellular OrganellesSignal TransductionAutophagosome Closure	2016	63
LBA32 Tisotumab vedotin in previously treated recurrent or metastatic cervical cancer: Results from the phase II innovaTV 204/GOG-3023/ENGOT-cx6 study Robert L. Coleman, Domenica Lorusso, Christine Gennigens, Annals of Oncology Metastatic Cervical CancerCervical CancerPhase IiMedicineCancer Management	2020	23
Interleukin-8 production from human somatotroph adenoma cells is stimulated by interleukin-1β and inhibited by growth hormone releasing hormone and somatostatin Signe Diness Vindeløv, Marie‐Louise Hartoft‐Nielsen, Åse Krogh Rasmussen, Growth Hormone & IGF Research InflammationCytokineGrowth HormoneHuman GrowthImmunology	2011	17

Page 1